IL6 and hyperinsulinemic hypoglycemia, familial, 4: And, SQS inhibitor lapaquistat acetate (TAK-475) could lower the elevated IL-6, and TNF-α caused by isoprenoids (GGPP and FPP, primary GGPP) in patients with mevalonate kinase deficiency (80, 95).